Other weight-loss drugs are currently in development or regulatory approval stages, including: Once-daily GLP-1 pill orforglipron (Eli Lilly), which, when taken alongside a healthy diet and exercise, resulted in a 7.5% weight loss over 72 weeks on the 6mg dose, 8.4% loss with 12mg of orforglipron, and 11.2% loss with 36mg of orforglipron, as compared with 2.1% loss with placebo (funded by Eli Lilly
Yes, creatine and tirzepatide operate through different biological pathways and don't have direct pharmacological interactions
Glucagon-like peptide 1 (GLP-1) receptor agonists are a class of medications that stimulate insulin production and suppress glucagon secretion
Research approaches include exercise testing protocols (treadmill, swim tests), muscle biopsies with metabolic analysis, non-invasive spectroscopy (31P-MRS for energetics), isolated muscle preparations, and satellite cell culture for regeneration studies
At our Palm Springs studio, we specialize in exactly this
